The subscription period of the rights issue in Serstech AB ended on January 30, 2018 and the result indicates that the rights issue was subscribed for to a total of approximately 197 percent. Through the rights issue, the Company will receive proceeds amounting to approximately SEK 24.6 million before issue costs.
“We are very happy for the high level of interest, from both smaller and larger investors. The proceeds allow us to quickly acquire the resources needed for our continued market expansion”, says Serstech CEO Stefan Sandor.
About Serstech AB
Serstech raises awareness of chemicals by combining measurements from a hand-held Raman spectrometer, Serstech 100 Indicator, with a secure system solution, ChemDash. The user-friendly solution identifies, manages and analyses chemicals which could affect public safety, such as explosives, narcotics and hazardous materials. Serstech has a global distribution network and main office is in Lund, Sweden and all development and manufacturing are done in Sweden. Serstech is listed on Nasdaq First North and the company’s certified adviser is Västra Hamnen Corporate Finance AB. Read more: www.serstech.com.
For further information, please contact:
Stefan Sandor, CEO Serstech AB
+46 739 – 60 60 67